Great question! First, you need to conduct IND-enabling studies (investigational new drug studies) before you can try the drug in humans. The costs to get a drug candidate ready for human studies can be several million USD, which is why this step usually requires venture capital in the private sector as it is usually beyond the scope of what can be done in an academic lab.
So at what point do you move to clinical trials? Does all that have to go through a government entity or privately funded?
Great question! First, you need to conduct IND-enabling studies (investigational new drug studies) before you can try the drug in humans. The costs to get a drug candidate ready for human studies can be several million USD, which is why this step usually requires venture capital in the private sector as it is usually beyond the scope of what can be done in an academic lab.